You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 19, 2024

BETAMETHASONE VALERATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Betamethasone Valerate, and what generic alternatives are available?

Betamethasone Valerate is a drug marketed by Novast Labs, Padagis Israel, Taro, Xiromed, Fougera Pharms Inc, Perrigo New York, Pharmaderm, Pharmafair, Anima, Teva Pharms, and Actavis Mid Atlantic. and is included in nineteen NDAs.

The generic ingredient in BETAMETHASONE VALERATE is betamethasone valerate. There are sixty-six drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the betamethasone valerate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Betamethasone Valerate

A generic version of BETAMETHASONE VALERATE was approved as betamethasone valerate by FOUGERA PHARMS INC on August 31st, 1983.

  Try a Trial

Drug patent expirations by year for BETAMETHASONE VALERATE
Drug Prices for BETAMETHASONE VALERATE

See drug prices for BETAMETHASONE VALERATE

Recent Clinical Trials for BETAMETHASONE VALERATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Assiut UniversityPhase 4
John HarrisPhase 2/Phase 3
Cairo UniversityPhase 4

See all BETAMETHASONE VALERATE clinical trials

Pharmacology for BETAMETHASONE VALERATE
Medical Subject Heading (MeSH) Categories for BETAMETHASONE VALERATE
Anatomical Therapeutic Chemical (ATC) Classes for BETAMETHASONE VALERATE
A07EA Corticosteroids acting locally
A07E INTESTINAL ANTIINFLAMMATORY AGENTS
A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS
A Alimentary tract and metabolism
C05AA Corticosteroids
C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE
C05 VASOPROTECTIVES
C Cardiovascular system
D07AC Corticosteroids, potent (group III)
D07A CORTICOSTEROIDS, PLAIN
D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS
D Dermatologicals
D07XC Corticosteroids, potent, other combinations
D07X CORTICOSTEROIDS, OTHER COMBINATIONS
D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS
D Dermatologicals
H02AB Glucocorticoids
H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
H02 CORTICOSTEROIDS FOR SYSTEMIC USE
H Systemic hormonal preparations, excluding sex hormones and insulins
R01AD Corticosteroids
R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE
R01 NASAL PREPARATIONS
R Respiratory system
R03BA Glucocorticoids
R03B OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS
R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R Respiratory system
S01BA Corticosteroids, plain
S01B ANTIINFLAMMATORY AGENTS
S01 OPHTHALMOLOGICALS
S Sensory organs
S01CB Corticosteroids/antiinfectives/mydriatics in combination
S01C ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION
S01 OPHTHALMOLOGICALS
S Sensory organs
S02BA Corticosteroids
S02B CORTICOSTEROIDS
S02 OTOLOGICALS
S Sensory organs
S03BA Corticosteroids
S03B CORTICOSTEROIDS
S03 OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS
S Sensory organs
Paragraph IV (Patent) Challenges for BETAMETHASONE VALERATE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
LUXIQ Foam betamethasone valerate 0.12% 020934 1 2007-08-10

US Patents and Regulatory Information for BETAMETHASONE VALERATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novast Labs BETAMETHASONE VALERATE betamethasone valerate AEROSOL, FOAM;TOPICAL 207144-001 May 24, 2017 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Pharmaderm BETAMETHASONE VALERATE betamethasone valerate OINTMENT;TOPICAL 018864-001 Aug 31, 1983 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Pharmaderm BETAMETHASONE VALERATE betamethasone valerate CREAM;TOPICAL 018860-002 Aug 31, 1983 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Xiromed BETAMETHASONE VALERATE betamethasone valerate AEROSOL, FOAM;TOPICAL 210639-001 Apr 18, 2023 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Pharmaderm BETAMETHASONE VALERATE betamethasone valerate LOTION;TOPICAL 018870-001 Aug 31, 1983 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Pharmafair BETAMETHASONE VALERATE betamethasone valerate CREAM;TOPICAL 070485-001 May 29, 1987 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Pharmafair BETAMETHASONE VALERATE betamethasone valerate OINTMENT;TOPICAL 070486-001 May 29, 1987 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.